When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

Are you a print subscriber? Activate your account. By Garett Sloane - 3 min 8 sec ago By Ewan Larkin - 8 min 31 sec ago By ...

See Also GLP-1s masterfully reduce the amount of inflammation in the body by stimulating weight ... “Novo Nordisk does not ...

(HealthDay News) — The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has ... for help with significant weight loss. While semaglutide remains on the shortage list, ...

The SA Health Products Regulatory Authority has expressed concern at the increasing presence of counterfeit products such as ...

These pose a health risk to the public. Sahpra cautions the public to not purchase and/or consume such products as their ...

Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...

Lars Fruergaard Jørgensen began his career at Novo Nordisk as an economist in the health care, economy, and planning ...

SAHPRA cautions the public to not purchase and/or consume such products as their safety, efficacy, and quality have not been ...

According to SAHPRA, GLP-1-containing products, like Ozempic, which help lower blood sugar levels and promote weight loss, ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...